Home Drug Codes J Codes J0013 · SPRAVATO
Updated July 1st, 2026

SPRAVATO J Code: J0013

Esketamine, nasal spray, 1 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
3
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Esketamine, nasal spray, 1 mg
HCPCS Added Date January 1, 2026
Manufacturer Janssen
Route of Administration Nasal
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Solution

About SPRAVATO

Spravato is a medication aligned to the HCPCS J Code: J0013 for billing, pricing, and reimbursement purposes in the United States. It is a Psychiatric drug administered via the nasal route and manufactured by Janssen.

Manufacturers, reach out to us to add more information.

NDC Code Information

3 NDC packages are crosswalked to J0013. Package detail is available to logged-in subscribers.

Login to view 3 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

SPRAVATO Pricing & Reimbursement

J0013 Private Payer Reimbursement
$14.75 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Esketamine 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J0013 Janssen Esketamine Esketamine, nasal spray, 1 mg
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

SPRAVATO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Depressive symptoms in MDD with acute suicidal ideation or behavior Treatment-resistant depression (TRD)

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there a manufacturer-published SPRAVATO billing and coding guide?
Billing and coding information for SPRAVATO can be found through Johnson & Johnson. Visit Here →
Is there an available SPRAVATO patient assistance program?
SPRAVATO patient assistance information can be found through Janssen. Visit Here →
Where can I find SPRAVATO prescribing information?
SPRAVATO prescribing information can be found at the link below. Visit Here →
Where can I find SPRAVATO side effect information?
SPRAVATO side effect information can be found through MedlinePlus. Visit Here →
Does billing SPRAVATO require JZ/JW wastage modifiers?
CMS does not include SPRAVATO (J0013) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0013. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.